medline.ch Onkologie Gynäkologische Tumoren

	Association of germline BRCA and homologous recombination deficiency with hematologic toxicity during platinum-taxane chemotherapy in ovarian cancer. Int J Clin Oncol Yoshida K, Araki H, Yamada Y, Masahashi Y, Miyamoto E, Katayama K, Kubokawa M, Mogi K, Yoshihara M, Nagao Y, Tamauchi S, Yokoi A, Yoshikawa N, Niimi K, Kajiyama H. PMID: 42204036 [PubMed - as supplied by publisher]
	Impact of breast cancer surgical procedures on postoperative daily life: a multicenter patient-reported outcomes study. Int J Clin Oncol Tsuchiya A, Seki H, Komiya T, Sowa Y, Kato M, Nishida Y, Saiga M, Collaborative Study Group of Scientific Research of the Japan Oncoplastic Breast Surgery Society. PMID: 42204031 [PubMed - as supplied by publisher]
	Dense-MoE vs Lite-MoE: A Gating-Weight-Aware Pruning Framework for Unpaired Multimodal Breast Cancer Diagnosis. J Imaging Inform Med Cetintas D, Tuncer T, Kilicarslan G, Sevi M. PMID: 42204022 [PubMed - as supplied by publisher]
	Survival outcomes with trastuzumab deruxtecan in HER2-positive vs. HER2-low breast cancer patients with brain metastases: a real-world cohort study. Sci Rep Podder V, Sarfraz Z, Ranjan T, McCracken A, Hurmiz C, Hodgson L, Maharaj A, Mahtani R, Ahluwalia MS. PMID: 42203808 [PubMed - as supplied by publisher]
	Quality of Life Outcomes Following Pelvic Exenteration for Gynaecological Malignancies: A Systematic Review. Anticancer Res Seksaf NA, Roberts HL, Lewis ME, Smits A, Oxley SG, Lymperopoulos N, Jeyarajah A, Manchanda R, Phadnis S, Sideris M. PMID: 42203329 [PubMed - indexed for MEDLINE]
	Dual Modality and Site-differentiated Sentinel Node Mapping in Vulvar Cancer. Anticancer Res Morgenstern B, Schmidt M, Thangarajah F. PMID: 42203323 [PubMed - indexed for MEDLINE]
	Standard Clinical Characteristics Fail to Predict Mild Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients. Anticancer Res Rades D, Streubel MK, Staackmann C, Doehring L, Rody A, Normann Haverberg MJ, Ballegaard M. PMID: 42203308 [PubMed - indexed for MEDLINE]
	Spuriously elevated estradiol due to immunoassay interference in the workup of a suspected ovarian tumor: Diagnostic pitfalls and laboratory workflow recommendations. Clin Biochem Lupoli GA, Polito C, Jannuzzi G, Fiorenza M, Marino A, Di Meglio L, Salvatore D, Terracciano D. PMID: 42203166 [PubMed - as supplied by publisher]
	Dual drug-loaded nanofibrous scaffolds for targeting dormant breast cancer cells: design, mechanisms, and translational perspectives. Int J Pharm Malarvannan M, Yadav D, Methri SM, Natesan S, Paul D. PMID: 42203084 [PubMed - as supplied by publisher]
	Emerging Biomarkers for the Early Detection of High-Grade Serous Tubo-Ovarian Cancer. Crit Rev Oncol Hematol Atiq S, Bowden NA, Warton K, Wong-Brown MW. PMID: 42202925 [PubMed - as supplied by publisher]
	A systematic review of pregnancy outcomes and management in polycystic ovary syndrome. Afr J Reprod Health Odunvbun WO, Ukoba O, Isogun JK, Ekoh A. PMID: 42202883 [PubMed - indexed for MEDLINE]
	Safety analyses of the INAVO120 randomised phase III trial of inavolisib or placebo with palbociclib-fulvestrant in patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative, endocrine-resistant advanced breast cancer. ESMO Open Im SA, Kalinsky K, Jhaveri KL, Loibl S, Turner N, Saura C, Schmid P, Loi S, Hamilton E, Karadurmus N, Wang S, Awan AA, Ciruelos EM, Chung CF, Thanopoulou E, Shankar N, Lim S, Jin Y, Song C, Juric D. PMID: 42202490 [PubMed - as supplied by publisher]
	Dynamic thymidine kinase activity independently captures treatment-specific biological response and is independently associated with outcomes in endocrine-resistant HR+â€¯/HER2â€¯- metastatic breast cancer: A translational analysis of the GEICAM/2013-02 PEARL trial. Eur J Cancer Guerrero-Zotano Á, Gil-Gil M, Williams A, Ruiz-Borrego M, Ritzén H, Ciruelos EM, Muñoz M, Bermejo B, Margelí M, Antón A, Kahan Z, Csöszi T, Murillo L, Murillo SM, Lang I, Rendo CR, Alba E, Álvarez P, de la Haba-Rodriguez J, Álvarez I, García A, Herranz J, Caballero R, Fisker H, Portela M, Rojo F, Martín M. PMID: 42202479 [PubMed - as supplied by publisher]
	Whole body vibration as an alternative to conventional aerobic and resistance training for managing chemotherapy-induced peripheral neuropathy in breast cancer survivors: The sensi-ex randomized trial. Eur J Oncol Nurs Mijwel S, Backman M, Anandavadivelan P, Tofthagen C, Wengström Y. PMID: 42202439 [PubMed - as supplied by publisher]
	High-Dose Sunitinib Accelerates Triple-Negative Breast Cancer Metastasis by Modulating an Immunosuppressive Microenvironment: A Preclinical 4T1 Model Study. Pharm Res Liu C, Xue J, Wang T, Hou X, Chen D, Wang Y, Zhou T. PMID: 42204130 [PubMed - as supplied by publisher]
	Pentagamavunone-1 inhibits aggressive breast cancer cell proliferation through mitotic catastrophe and ROS-mediated activities: in vitro and in vivo studies. Saudi Pharm J Novitasari D, Nakamae I, Istighfari Jenie R, Yoneda-Kato N, Kato JY, Meiyanto E. PMID: 42204109 [PubMed]
	Optimization of Pathologists' Roles in Molecular Biomarker Testing in Metastatic Breast Cancer: A Consensus Statement. J Mol Diagn Kolhe R, Karakas C, Vail E, Deftereos G, Sidiropoulos N. PMID: 42202906 [PubMed - as supplied by publisher]
	Primary Platinum-Resistant Ovarian Cancer: Clinicopathologic Correlates and Outcomes From a Multicenter Prospective Indian Registry. JCO Glob Oncol Sehrawat A, Singh L, Sundriyal D, Rajaram S, Natarajan S, Kumari A, Panda SS, Cyriac SL, Rathnam K, Philips AO, Moharana L, Samantaray L, Sv S, Yeshala SK, Batta N, Singh A, P V, Chaturvedula L, D J, Vc S, S P, Ch Toi P, Ganesan P. PMID: 42202250 [PubMed - indexed for MEDLINE]
	Dynamic Evolution of HER2 Expression Following Neoadjuvant Therapy and Its Association With Treatment Response and Prognosis in Breast Cancer: A Large-Scale Retrospective Study. World J Surg Wang S, Liu T, Liu X, Liu L, Ma T, Shi Z, Liu J, Zhang J. PMID: 42202038 [PubMed - as supplied by publisher]
	ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma-cfDNA of advanced breast cancer patients: A feasibility proof-of-concept study. Mol Oncol Stergiopoulou D, Markou A, Nicolo E, Serafini MS, Zhang Q, Zhang Y, Gerratana L, Davis AA, Liu H, Gradishar WJ, Reduzzi C, Cristofanilli M, Lianidou E. PMID: 42201922 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 329382

Seite 1 von 16470

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung